Inventor · disambiguated record
Shelley Allen
Also filed as: ALLEN SHELLEY · ALLEN SHELLEY J · ALLEN SHELLEY JANE
44 granted patents·16 pending applications·298 citations·filing 2001–2025
98Inventor score
Top patents by PatentIndex Score
60 records- 0197US8791123B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsALLEN SHELLEY·Filed 2010·Granted Jul 29, 2014·94 cites·61 claims
- 0296US11453683B1KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·13 cites·84 claims
- 0396US9796724B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 24, 2017·16 cites·30 claims
- 0496US9782415B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 10, 2017·19 cites·30 claims
- 0596US7449486B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Nov 11, 2008·37 cites·34 claims
- 0695US9682979B2Substituted pyrazolo [1,5-A] pyrimidine compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Jun 20, 2017·27 cites·43 claims
- 0792US11964989B2KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·2 cites·19 claims
- 0889US11802127B23,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitorsPFIZER·Filed 2022·Granted Oct 31, 2023·1 cites·53 claims
- 0989US10730880B24,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Aug 4, 2020·4 cites·25 claims
- 1089US7795282B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Sep 14, 2010·9 cites·2 claims
- 1188US11780835B2Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinasesARRAY BIOPHARMA INC·Filed 2021·Granted Oct 10, 2023·1 cites·9 claims
- 1288US10251889B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Apr 9, 2019·4 cites·18 claims
- 1388US7956073B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2008·Granted Jun 7, 2011·8 cites·11 claims
- 1487US9878997B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jan 30, 2018·4 cites·10 claims
- 1587US9562055B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsALLEN SHELLEY·Filed 2012·Granted Feb 7, 2017·8 cites·61 claims
- 1687US9221841B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2015·Granted Dec 29, 2015·5 cites·19 claims
- 1787US8236825B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2011·Granted Aug 7, 2012·7 cites·24 claims
- 1885US8268871B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2010·Granted Sep 18, 2012·7 cites·10 claims
- 1984US11104676B2Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinasesARRAY BIOPHARMA INC·Filed 2019·Granted Aug 31, 2021·1 cites·4 claims
- 2084US9896435B2N-pyrrolidinyl,N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Feb 20, 2018·3 cites·29 claims
- 2183US8623895B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2012·Granted Jan 7, 2014·4 cites·104 claims
- 2282US10323022B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 18, 2019·2 cites·26 claims
- 2382US9102639B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2013·Granted Aug 11, 2015·3 cites·22 claims
- 2482US8580828B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2012·Granted Nov 12, 2013·5 cites·35 claims
- 2578US10189845B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Jan 29, 2019·2 cites·20 claims
- 2678US2024174666A1PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASESARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2777US8138181B2Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitorsALLEN SHELLEY·Filed 2008·Granted Mar 20, 2012·3 cites·29 claims
- 2877US2024309020A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2976US11691973B23,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitorsPFIZER·Filed 2022·Granted Jul 4, 2023·0 cites·11 claims
- 3075US11247990B1Bicyclic fused pyridine compounds as inhibitors of TAM kinasesARRAY BIOPHARMA INC·Filed 2018·Granted Feb 15, 2022·1 cites·20 claims
- 3175US2024002384A13,4-dihydro-2,7-naphthyridine-1,6(2h,7h)-diones as mek inhibitorsPFIZER·Filed 2023·Application pending·0 cites
- 3274US9499503B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2015·Granted Nov 22, 2016·1 cites·18 claims
- 3374US8557809B2Triazolopyridine compounds as PIM kinase inhibitorsALLEN SHELLEY·Filed 2009·Granted Oct 15, 2013·2 cites·17 claims
- 3471US8575145B2Triazolopyridine compounds as PIM kinase inhibitorsALLEN SHELLEY·Filed 2009·Granted Nov 5, 2013·2 cites·29 claims
- 3571US2025263411A13,4-dihydro-2,7-naphthyridine-1,6(2h,7h)-diones as mek inhibitorsPFIZER·Filed 2025·Application pending·0 cites
- 3670US10758542B2Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Sep 1, 2020·0 cites·11 claims
- 3770US10351575B2Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of painARRAY BIOPHARMA INC·Filed 2013·Granted Jul 16, 2019·1 cites·48 claims
- 3868US9546156B2N-bicyclic aryl,N'-pyrazolyl urea, thiourea, guanidine cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Jan 17, 2017·1 cites·25 claims
- 3967US2018334441A1Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2018·Application pending·0 cites
- 4066US10835533B21 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitorARRAY BIOPHARMA INC·Filed 2015·Granted Nov 17, 2020·1 cites·5 claims
- 4164US11028093B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Jun 8, 2021·0 cites·19 claims
- 4263US10889589B2Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of painARRAY BIOPHARMA INC·Filed 2019·Granted Jan 12, 2021·0 cites·34 claims
- 4363US10017482B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2016·Granted Jul 10, 2018·0 cites·15 claims
- 4463US2019359597A1Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 4561US2014018399A1Mitotic kinesin inhibtors and methods of use thereofARRAY BIOPHARMA INC·Filed 2013·Application pending·0 cites
- 4659US10851080B2Methods of treatment using pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compoundsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 1, 2020·0 cites·16 claims
- 4757US2003096753A1Therapeutic agentFiled 2002·Application pending·0 cites
- 4855US2023357277A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4955US2007067857A1Therapeutic agent for NGFUNIV BRISTOL·Filed 2006·Application pending·0 cites
- 5054US2004037831A1Pharmaceutical compositon comprising trkaig2 for use inthe prevention and/or treatment of cancerFiled 2001·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Shelley Allen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →